In recent years, ultrasmall Bi NPs, labeled with a peptide LyP-1, have showed high tumor uptake, offering a potential theranostic contrast agent for PAI, CT, and combined PTT-RT [62]. The gene discussed is PTPN22; the disease is neoplasm.